Peter N Stephens
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Pharmaceutical Economics and Policy 10
-
- Attention Deficit Hyperactivity Disorder 1
- Dementia and Cognitive Impairment Research 1
- Co-authors
- Virve I. Enne (1 shared paper)David M. Livermore (1 shared paper)Lucinda M. C. Hall (1 shared paper)Warren Kaplan (1 shared paper)Veronika J. Wirtz (1 shared paper)Ian Chi Kei Wong (2 shared papers)Dennis Ross‐Degnan (6 shared papers)Anita Katharina Wagner (6 shared papers)
- Journals
- The Lancet (2 papers)Journal of Pharmaceutical Policy and Practice (2 papers)Drug Safety (1 paper)Health Policy (1 paper)BMJ Open (1 paper)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Peter N Stephens
16 papers receiving 994 citations
Peter N Stephens's Hit Papers
Peers
Comparison fields: 5 of 102
- Applied Microbiology and Biotechnology 172
- Molecular Medicine 182
- Economics and Econometrics 342
- Pollution 98
- Finance 67
Countries citing papers authored by Peter N Stephens
This map shows the geographic impact of Peter N Stephens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter N Stephens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter N Stephens more than expected).
Fields of papers citing papers by Peter N Stephens
This network shows the impact of papers produced by Peter N Stephens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter N Stephens. The network helps show where Peter N Stephens may publish in the future.
Co-authors
The 22 scholars most cited alongside Peter N Stephens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Essential medicines for universal health coverage Hit paper breakdown → | 2016 | 437 |
| 2 | 2001 | 417 | |
| 3 | 2019 | 58 | |
| 4 | 2013 | 44 | |
| 5 | 2012 | 22 | |
| 6 | 2013 | 14 | |
| 7 | 2003 | 13 | |
| 8 | 2014 | 11 | |
| 9 | 2015 | 9 | |
| 10 | 2014 | 8 | |
| 11 | 2020 | 7 | |
| 12 | 2013 | 6 | |
| 13 | 2019 | 6 | |
| 14 | 2018 | 5 | |
| 15 | 2019 | 5 | |
| 16 | 2014 | 1 |
About Peter N Stephens
Peter N Stephens is a scholar working on Economics and Econometrics, Psychiatry and Mental health, Applied Microbiology and Biotechnology, Geriatrics and Gerontology and Molecular Medicine, having authored 16 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (10 papers), Biotechnology and Related Fields (1 paper), Attention Deficit Hyperactivity Disorder (1 paper), Child and Adolescent Psychosocial and Emotional Development (1 paper), Health and Medical Research Impacts (1 paper), Dementia and Cognitive Impairment Research (1 paper), Sex and Gender in Healthcare (1 paper) and Diabetes Treatment and Management (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (172 citations), Molecular Medicine (182 citations), Economics and Econometrics (342 citations), Pollution (98 citations) and Finance (67 citations). Peter N Stephens has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Virve I. Enne, David M. Livermore, Lucinda M. C. Hall, Warren Kaplan, Veronika J. Wirtz, Ian Chi Kei Wong, Dennis Ross‐Degnan, Anita Katharina Wagner, Yingfen Hsia and Mike Sharland. Their work appears in journals such as The Lancet, Journal of Pharmaceutical Policy and Practice, Drug Safety, Health Policy and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.